title: Experimental heart preservation for 24 hours: benefits of PGE1 in a nonpulsatile coronary perfusion solution.
authors.affiliation: Clinica Universitaria de Navarra, Pamplona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Herreros
authors.forename: A R
authors.initials: AR
authors.lastname: Abaya
authors.forename: L
authors.initials: L
authors.lastname: Ponz
authors.forename: J M
authors.initials: JM
authors.lastname: Gil
authors.forename: R
authors.initials: R
authors.lastname: Llorens
authors.forename: P
authors.initials: P
authors.lastname: Errasti
authors.forename: R
authors.initials: R
authors.lastname: Arcas
mesh_terms: D000527:Alprostadil / Q000494:pharmacology; D000818:Animals; D002314:Cardioplegic Solutions; D004285:Dogs; D006321:Heart / Q000502:physiology; D016027:Heart Transplantation; D009200:Myocardial Contraction / Q000187:drug effects; D009926:Organ Preservation / Q000379:methods; D009929:Organ Size / Q000187:drug effects; D010477:Perfusion / Q000379:methods; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D002314:Cardioplegic Solutions; D000527:Alprostadil